The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pittsburgh Compound B (PiB) PET imaging measures of Amyloid-‐β protein deposition, a neuropathological hallmark of Alzheimer’s disease (AD), in both cross-‐sectional and longitudinal studies. Simulated phantoms based on existing MR and PiB PET images were generated to characterize and validate the implementation of three partial volume correction (PVC) techniques that account for the limited spatial resolution of PET: the Meltzer, the Müller-‐Gärtner, and the Region-‐Based Voxel-‐Wise methods. The impact of these partial volume correction methods on correlations between region-‐matched antemortem PiB PET standardized uptake value ratios (SUVR)...
Abstract: Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s ...
Background: Quantitative evaluation of amyloid positron emission tomography(PET) with standardized u...
© 2020 The Authors.Positron emission tomography (PET)‐based staging of regional amyloid deposition h...
<p>The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pitt...
Positron emission tomography (PET) allows for in vivo visualisation and quantification of amyloid-β ...
The positron emission tomography (PET) radiotracer Pittsburgh Compound B ([C-11]PiB) demonstrates a ...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
AbstractQuantitative measurements of change in β-amyloid load from Positron Emission Tomography (PET...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer's disease (AD)...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Abstract: Deposition of amyloid and tau pathology can be quantified in vivo using positron emission...
Abstract: Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s ...
Background: Quantitative evaluation of amyloid positron emission tomography(PET) with standardized u...
© 2020 The Authors.Positron emission tomography (PET)‐based staging of regional amyloid deposition h...
<p>The aim of this work was to identify optimal methodological techniques for quantifying 11C-‐Pitt...
Positron emission tomography (PET) allows for in vivo visualisation and quantification of amyloid-β ...
The positron emission tomography (PET) radiotracer Pittsburgh Compound B ([C-11]PiB) demonstrates a ...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
AbstractQuantitative measurements of change in β-amyloid load from Positron Emission Tomography (PET...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s disease (AD)...
Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer's disease (AD)...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Imaging-pathological correlation studies show that in vivo amyloid-β (Aβ) positron emission tomograp...
Abstract: Deposition of amyloid and tau pathology can be quantified in vivo using positron emission...
Abstract: Amyloid-β (Aβ) pathology is one of the earliest detectable brain changes in Alzheimer’s ...
Background: Quantitative evaluation of amyloid positron emission tomography(PET) with standardized u...
© 2020 The Authors.Positron emission tomography (PET)‐based staging of regional amyloid deposition h...